INmune Bio, Inc.INMBNASDAQ
LOADING
|||
Cash Flow Performance
Trending lower, below historical average, strong compound growth.
Left:
||||
Free cash flow yield
Latest
-35.82%
↓ 239% below average
Average (9y)
-10.56%
Historical baseline
Range
High:-0.05%
Low:-35.82%
CAGR
+109.9%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | -35.82% | -505.3% |
| 2023 | -5.92% | +70.4% |
| 2022 | -19.96% | +24.5% |
| 2021 | -26.44% | -510.3% |
| 2020 | -4.33% | +52.1% |
| 2019 | -9.04% | -293.4% |
| 2018 | -2.30% | -138.9% |
| 2017 | -0.96% | -23.6% |
| 2016 | -0.78% | -1614.6% |
| 2015 | -0.05% | - |